Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19

NCT04709835 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: AT-527
DRUG: Placebo

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]